1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Johnson & Weaver, LLP Announces Investigation into Possible Acquisition of Illumina, Inc. by Roche

Johnson & Weaver has launched an investigation into possible breaches of fiduciary duty to current shareholders of Illumina, Inc. and other violations of law by the board of directors of Illumina relating to Roche's proposed acquisition of Illumina.

 
PRLog - Jan. 25, 2012 - SAN DIEGO -- Johnson & Weaver, LLP has launched an investigation into possible breaches of fiduciary duty to current shareholders of Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN) and other potential violations of law by the board of directors of Illumina (the “Board”) relating to the proposed acquisition of the Company by Roche. The firm is investigating, among other things, whether the Board breached its fiduciary duties by disregarding and responding unreasonably to Roche’s offer to acquire Illumina well above its market price.
   
On January 25, 2012, Roche announced that it is proposing to acquire all outstanding shares of Illumina for $44.50 per share in cash, or an aggregate of approximately $5.7 billion. According to Roche's press release, this offer represents a 64% premium over Illumina’s stock price on December 21, 2011 (the day before market rumors about a potential transaction between Roche and Illumina drove Illumina’s stock price substantially higher), a 61% premium over the one-month historical average, and a 43% premium over the three-month historical average of Illumina’s share price, both as of December 21. It also represents a 30.1x multiple of Illumina’s projected forward earnings based upon analysts’ current consensus estimates for 2012.

According to its press release, Roche has made multiple efforts to convene with Illumina’s Board in order to reach a negotiated transaction.  The Board has been unwilling, however, to participate in substantive discussions. As a result, Roche commenced a tender offer to purchase all of the outstanding shares of common stock of Illumina.

If you currently own shares of Illumina and would like to learn more about the investigation being conducted by Johnson & Weaver you may email or call Frank Johnson who will, without obligation or cost to you, address your questions. You may contact Mr. Johnson by email at frankj@johnsonandweaver.com or by calling (619)-230-0063. The attorneys at Johnson & Weaver, LLP are experienced and have been extremely effective in litigating securities and class action cases.

Contacts:

Johnson & Weaver, LLP
San Diego, CA
Frank J. Johnson (619) 230-0063
frankj@johnsonandweaver.com
www.johnsonandweaver.com

--- End ---

Click to Share

Contact Email:
***@johnsonandweaver.com Email Verified
Source:Frank J. Johnson
Phone:(619) 230-0063
Zip:92101
Location:San Diego - California - United States
Industry:Legal
Tags:Finance, illumina, roche, acquisition, legal, buyout, shareholder, investor, fiduciary, lawsuit
Shortcut:prlog.org/11782024
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share